These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16291725)

  • 21. btn1 affects endocytosis, polarization of sterol-rich membrane domains and polarized growth in Schizosaccharomyces pombe.
    Codlin S; Haines RL; Mole SE
    Traffic; 2008 Jun; 9(6):936-50. PubMed ID: 18346214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae model for Batten disease.
    Vitiello SP; Benedict JW; Padilla-Lopez S; Pearce DA
    Hum Mol Genet; 2010 Mar; 19(5):931-42. PubMed ID: 20015955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannosylinositol phosphorylceramide is a major sphingolipid component and is required for proper localization of plasma-membrane proteins in Schizosaccharomyces pombe.
    Nakase M; Tani M; Morita T; Kitamoto HK; Kashiwazaki J; Nakamura T; Hosomi A; Tanaka N; Takegawa K
    J Cell Sci; 2010 May; 123(Pt 9):1578-87. PubMed ID: 20388730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease.
    Minnis CJ; Townsend S; Petschnigg J; Tinelli E; Bähler J; Russell C; Mole SE
    Sci Rep; 2021 Mar; 11(1):6332. PubMed ID: 33737578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizosaccharomyces pombe stt3+ is a functional homologue of Saccharomyces cerevisiae STT3 which regulates oligosaccharyltransferase activity.
    Yoshida S; Matsuura A; Merregaert J; Anraku Y
    Yeast; 1999 Apr; 15(6):497-505. PubMed ID: 10234787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-dependent localization of Btn1p in the yeast model for Batten disease.
    Wolfe DM; Padilla-Lopez S; Vitiello SP; Pearce DA
    Dis Model Mech; 2011 Jan; 4(1):120-5. PubMed ID: 20959629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and chromosomal mapping of a mouse homolog of the Batten disease gene CLN3.
    Lee RL; Johnson KR; Lerner TJ
    Genomics; 1996 Aug; 35(3):617-9. PubMed ID: 8812504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a second gene encoding gamma-glutamyl transpeptidase from Schizosaccharomyces pombe.
    Park HJ; Moon JS; Kim HG; Kim IH; Kim K; Park EH; Lim CJ
    Can J Microbiol; 2005 Mar; 51(3):269-75. PubMed ID: 15920625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 32. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 33. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
    Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical localization of the Batten disease (CLN3) protein in retina.
    Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-species homology of the CLN3 gene.
    Taschner PE; de Vos N; Breuning MH
    Neuropediatrics; 1997 Feb; 28(1):18-20. PubMed ID: 9151313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning and sequencing of Schizosaccharomyces pombe car1 gene encoding arginase. Expression of the arginine anabolic and catabolic genes in response to arginine and related metabolites.
    Van Huffel C; Dubois E; Messenguy F
    Yeast; 1994 Jul; 10(7):923-33. PubMed ID: 7985419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of end4+, a gene required for endocytosis in Schizosaccharomyces pombe.
    Iwaki T; Tanaka N; Takagi H; Giga-Hama Y; Takegawa K
    Yeast; 2004 Jul; 21(10):867-81. PubMed ID: 15300681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farnesylation of Batten disease CLN3 protein.
    Pullarkat RK; Morris GN
    Neuropediatrics; 1997 Feb; 28(1):42-4. PubMed ID: 9151320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.